Fosun-backed Sisram Med lines up $200m HK float
Fosun International-backed Sisram Medical is looking to list in Hong Kong for around $200m, filing a draft prospectus on Wednesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: